Results from clinical trials and clinical guidelines indicate that long term use of either roflumilast or azithromycin significantly reduces the risk of COPD exacerbations. No studies to date have directly compared long term roflumilast to azithromycin in patients with COPD, so it is unclear how well they work when compared to each other. The RELIANCE study aims to compare roflumilast and azithromycin head-to-head to determine which therapy is best for the prevention of COPD exacerbations. The study has been proposed, but is not yet active, or IRB approved.
Please contact firstname.lastname@example.org for more information.
RELIANCE for Clinicians at a Glance